researchdrivelogo.jpg
Global Medical Tourism Market Anticipated to Garner Significant Revenue of $149.34 Billion by 2026 at a stable CAGR of 12.4% from 2019-2026 - Exclusive Report [140-Pages] by Research Dive
22 sept. 2021 09h00 HE | Research Dive
New York, USA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- As per the latest report published by Research Dive, the global medical tourism market is predicted to witness a significant rise in revenue...
CVRx Logo_R_RGB_black.png
CVRx Added to Russell 2000® and 3000® Indexes
17 sept. 2021 08h00 HE | CVRx, Inc.
MINNEAPOLIS, Sept. 17, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...
Owkin Enters Into Agreement to Build Innovative Methods With the Potential to Enhance AI-Enabled External Control Arms
15 sept. 2021 09h00 HE | Owkin
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announces an agreement with Actelion...
researchdrivelogo.jpg
Global Medical Tourism Market Expected to Generate a Revenue of $142.2 Billion by 2026, Growing at a CAGR of 11.7% from 2019-2026 COVID-19 impact - Exclusive Report by Research Dive
14 sept. 2021 09h01 HE | Research Dive
New York, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to generate a revenue of $142.2 billion by 2026,...
gmi logo.jpg
Medical Biomimetics Market Revenue 2021: Top 4 Trends Driving the Industry Expansion Through 2027; Global Market Insights Inc.
18 août 2021 06h00 HE | Global Market Insights, Inc
Selbyville, Delaware, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The medical biomimetics market size is anticipated to record a valuation of USD 53 billion by 2027, according to the most recent study by...
CVRx Logo_R_RGB_black.png
CVRx Reports Second Quarter 2021 Financial and Operating Results
04 août 2021 16h05 HE | CVRx, Inc.
MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...
CVRx Logo_R_RGB_black.png
CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference
29 juil. 2021 16h05 HE | CVRx, Inc.
MINNEAPOLIS, July 29, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology
28 juil. 2021 08h00 HE | ARCA biopharma, Inc.
Analysis in full patient cohort shows Gencaro effect compared to standard of careIn the GENETIC-AF entire cohort of heart failure patients treated with Gencaro, compared to patients treated with...
CVRx Logo_R_RGB_black.png
CVRx to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call
21 juil. 2021 17h28 HE | CVRx, Inc.
MINNEAPOLIS, July 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally...
CVRx Welcomes Veteran Life Science Industry Leader Martha Shadan to its Board of Directors
12 juil. 2021 08h00 HE | CVRx, Inc.
MINNEAPOLIS, July 12, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally...